Related Experiment Videos
PDE4 inhibitors: new xanthine analogues
J G Montana1, N Cooper, H J Dyke
1Chiroscience Ltd, Cambridge Science Park, UK. johnmontana@chiroscience.com
Bioorganic & Medicinal Chemistry Letters
|January 5, 1999
Abstract:
Novel xanthine analogues are described which are selective PDE4 inhibitors with improved therapeutic potential over theophylline.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Diagnostic imaging of adnexal lesions in pregnancy: systematic review.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
Documenting interventions delivered by the Disability Liaison Officer Program to achieve equity in healthcare.
Disability and rehabilitation·2025
Clinical utility of ultrasonography in pediatric and adolescent gynecology: retrospective review of 1313 ultrasound examinations.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Evaluating use of two-step International Ovarian Tumor Analysis strategy to classify adnexal masses identified in pregnancy: pilot study.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2024
Structure-activity profiling of indazole-based derivatives as spinster homolog 2 (Spns2)-dependent S1P release inhibitors.
Bioorganic & medicinal chemistry letters·2026
Synthesis and discovery of polyisopentenylated acylphloroglucinols with selective antiproliferative activity against breast cancer cells.
Bioorganic & medicinal chemistry letters·2026
Photocaging of a GPR52 agonist enables light-dependent receptor activation in cells.
Bioorganic & medicinal chemistry letters·2026
Discovery of potent, selective, and orally bioavailable monocyclic pyridine-based PKMYT1 inhibitors that synergize with CHK1 inhibition in replication-stressed cancer cells.
Bioorganic & medicinal chemistry letters·2026
Quinolin(on)es and pyridin(on)es as promising scaffolds against mycobacterial infections.
Bioorganic & medicinal chemistry letters·2026
An integrated in vitro and in silico approach to evaluate the safety and wound healing potential of Dracocephalum moldavica L. seed oil.
Toxicology in vitro : an international journal published in association with BIBRA·2026
Unraveling the allosteric inhibition mechanism of TLR2 by CU-CPT22: A combined DFT and enhanced sampling MD study.
Journal of molecular graphics & modelling·2026